The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
The company sees the business reaching $100mn
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
_256_384.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
Govt committed to supporting pharma companies with industry-friendly policies
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
Subscribe To Our Newsletter & Stay Updated
